SNDX - FDA grants priority review for Syndax leukemia drug sets action date
2024-03-26 17:11:27 ET
More on Syndax Pharmaceuticals
- Syndax Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
- Syndax Pharmaceuticals, Inc. (SNDX) Q4 2023 Earnings Call Transcript
- FDA accepts Incyte application for graft-versus-host disease drug
- Barron’s cites cancer and weight loss plays for biotech M&A
- Seeking Alpha’s Quant Rating on Syndax Pharmaceuticals